| Patient | Sarah Walker |
|---|---|
| Date of birth | 1867-12-23 |
| Identifiers | MRN HR-ET019-SYN-TD; SSN (made up) 000-19-7062 |
| Document date | 1917-04-13 |
| Author | Harriet Okonjo-Bell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Vomiting and diarrhea since the day before yesterday. [S]
Madam Walker called this morning and was seen the same day. She came home two days ago from a sales convention where several agents had a stomach illness. That night she began vomiting, four times by morning, with six loose watery stools over the next day and cramping around the navel. The vomiting stopped yesterday afternoon; she is keeping down sips of broth and an oral rehydration drink, and the diarrhea has slowed to two stools today. No blood in the stool and no fever above 37.5 °C. She feels light-headed when she stands quickly. Following the sick-day card in her bag, she has not taken losartan or empagliflozin since the vomiting began; she took nothing for pain. She has kept taking atorvastatin. She is passing less urine than usual. [S]
| Element | Detail |
|---|---|
| Onset | Two nights ago, after a sales convention |
| Duration | About 36 hours |
| Character | Vomiting, watery diarrhea, crampy pain around the navel |
| Severity | Moderate; vomiting stopped; two stools today |
| Context | Stomach illness among agents at the convention; CKD G3a on losartan 100 mg and empagliflozin |
| Modifying factors | Losartan and empagliflozin held under her sick-day rules; rehydration drink |
| Associated signs and symptoms | Light-headed on standing; less urine; no blood in the stool, no high fever |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; temperature up to 37.5 °C at home |
| Gastrointestinal | Positive | Vomiting stopped; watery diarrhea slowing; crampy pain; no blood or black stool |
| Genitourinary | Positive | Passing less urine; no burning |
| Cardiovascular | Positive | Light-headed on standing; no chest pain or palpitations |
| Neurological | Negative | No confusion, weakness or severe headache |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Losartan 50 mg oral tablet, one tablet each morning | One tablet each morning, at the same home time when traveling | Oral route | 1917-02-23 to 1917-03-09 | completed | S |
| Losartan 100 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1917-03-09 | active | S |
| Empagliflozin 10 mg oral tablet, one tablet each morning; stop on days of vomiting, diarrhea or not eating, and before surgery | One tablet each morning, with sick-day rules | Oral route | 1917-02-23 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1917-02-23 | active | S |
| Ondansetron 4 mg orally disintegrating tablet, one tablet on the tongue every 8 hours as needed for nausea, for up to two days | Every 8 hours as needed for nausea, up to two days | Oral route | 1917-04-13 to 1917-04-15 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1917-04-13 | Body height | 163 | cm | S |
| 1917-04-13 | Body weight | 76.4 | kg | S |
| 1917-04-13 | Body mass index (BMI) [Ratio] | 28.8 | kg/m2 | S |
| 1917-04-13 | Systolic blood pressure | 112 | mm[Hg] | S |
| 1917-04-13 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 1917-04-13 | Heart rate | 96 | /min | S |
| 1917-04-13 | Respiratory rate | 16 | /min | S |
| 1917-04-13 | Body temperature | 37.4 | Cel | S |
| 1917-04-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1917-04-13 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1917-04-13 | Potassium [Moles/volume] in Serum or Plasma | 4.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1917-04-13 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 21 | mmol/L | 22-29 mmol/L | Low | S |
| 1917-04-13 | Creatinine [Mass/volume] in Serum or Plasma | 1.46 | mg/dL | 0.59-1.04 mg/dL | High | S |
| 1917-04-13 | Glucose [Mass/volume] in Serum or Plasma | 88 | mg/dL | 70-99 mg/dL | Normal | S |
| 1917-04-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1912)/1.73 sq M | 44 | mL/min/{1.73_m2} | 60 or higher (G1 to G2) unless other kidney damage; 45 to 59 is G3a | Low | S |
Vital signs recorded on 1917-04-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Tired but alert and talking easily; temperature 37.4 °C |
| Blood pressure lying and standing | 112/72 with pulse 96 lying; 102/66 with pulse 108 after two minutes standing, with light-headedness |
| Mouth | Mucous membranes slightly dry |
| Abdomen | Soft; mild tenderness around the navel without guarding; active bowel sounds; no rebound |
| Skin | Skin turgor slightly reduced; no rash |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Elevated blood pressure at intake (166/102 mmHg, average of two readings), first found at a workplace screening; ambulatory monitoring to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding, superseded by the confirmed diagnosis at two weeks. |
| Albumin in the urine (urine albumin-to-creatinine ratio 286 mg/g) with eGFR 54 by the race-free CKD-EPI 1912 equation; she recalls protein in the urine at an executive physical a year ago, and those records are requested; to be repeated and investigated | resolved | confirmed | R80.9 | S — Synthetic presenting finding, superseded by the kidney diagnosis at two weeks. |
| Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (24-hour mean 149/94, daytime 154/98, night 140/88 without the normal nighttime fall), with left ventricular hypertrophy on ECG and mild hypertensive retinopathy; synthetic modern episode linked to her documented high blood pressure | active | confirmed | I12.9 | S — Synthetic modern diagnosis anchored to the documented hypertension and nephritis. |
| Chronic kidney disease G3a A2 (eGFR 54 to 55 mL/min/1.73 m2 by the race-free CKD-EPI 1912 equation; albumin-to-creatinine ratio 286 to 294 mg/g; present for more than three months), most likely hypertensive kidney disease; bland urine sediment and normal-sized kidneys on ultrasound; 5-year kidney failure risk 1.6% | active | confirmed | N18.31 | S — Synthetic kidney findings anchored to the documented nephritis and death from kidney disease. |
| Hyperlipidemia: LDL 174 mg/dL; 10-year ASCVD risk 7.9% by the Pooled Cohort Equations (intermediate) | active | confirmed | E78.5 | S — Synthetic laboratory finding. |
| Viral gastroenteritis after a sales convention, with mild volume depletion and losartan and empagliflozin held under her sick-day rules; no acute kidney injury; resolved | active | confirmed | A08.4 | S — Synthetic intercurrent illness; not a historical claim. |
Guideline basis: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024)
Follow-up: Nurse phone call tomorrow. Metabolic panel within a week; eleven-week review in two weeks as booked. Emergency care for vomiting that stops her drinking, fainting, no urine for 12 hours, or blood in the stool. Next scheduled visit 1917-04-27: eleven-week review: home readings on maximum losartan, urine albumin, kidney function after a recent gastroenteritis, lipids on atorvastatin. [S]